Find uplifting stories about heroes, innovations, and solutions
2960 results for "ovarian cancer"
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
When Caitlin Koehler was diagnosed with an extremely rare ovarian cancer at 27, she trusted MD Anderson's expert team to create a personalized treatment plan. Now cancer-free after beating two recurrences, she's proof that specialized care makes all the difference for young adults facing rare diagnoses.
The NHS just approved a groundbreaking ovarian cancer treatment that works like a guided missile, targeting only cancer cells while leaving healthy tissue untouched. For women with platinum-resistant ovarian cancer who had almost no options left, this precision medicine marks a genuine turning point. #
Women with hard-to-treat ovarian cancer now have a breakthrough treatment that adds precious months to their lives while making them feel better. The targeted drug has been called the most significant advance in ovarian cancer care in over 20 years.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
Researchers discovered that ovarian cancer cells activate survival mode within hours of treatment, but an existing lung cancer drug can block this response. The breakthrough could help thousands of women whose tumors stop responding to therapy.
Hundreds of women with chemotherapy-resistant ovarian cancer in England now have access to a groundbreaking treatment that extends life and shrinks tumors. It's the first new option approved for this hard-to-treat cancer in two decades.
Japanese researchers discovered that ovarian cancer cells team up with other cells in the body to spread faster and resist treatment. The breakthrough could lead to new drugs that save thousands of lives each year.
Scientists created a "smart" nanoparticle that targets ovarian cancer cells while leaving healthy tissue untouched. The breakthrough could make treatment safer and more effective for thousands of women.
Women with a hard-to-treat form of ovarian cancer now have access to a diagnostic test that could connect them with life-extending treatment options. The nationwide rollout marks a breakthrough for patients who previously faced limited hope.
A groundbreaking treatment just became available to thousands of European women whose ovarian cancer stopped responding to standard chemotherapy. The approval marks the first time an immunotherapy has been authorized in the EU for this hard-to-treat condition.
A breakthrough ovarian cancer treatment now available on the NHS extends patient lives by nearly four months while dramatically reducing side effects. Women can now keep their hair, enjoy family gatherings, and live fuller lives during treatment.
A groundbreaking ovarian cancer treatment now available on the NHS works like a "biological missile," delivering chemotherapy directly to tumors while sparing the rest of the body. Patients are living longer, keeping their hair, and reclaiming activities they thought they'd lost forever.
A groundbreaking treatment is giving hope to women with advanced platinum-resistant ovarian cancer, a diagnosis that has long meant limited options. In early trials, more than half of patients saw their tumors shrink.
Women with hard-to-treat ovarian cancer now have access to a nationwide diagnostic test that identifies who can receive a newly approved therapy shown to extend survival. Labcorp's rapid rollout means patients can get tested and connected to treatment quickly.
After two decades without a breakthrough, England's health service has approved a targeted therapy that offers new hope to women with hard-to-treat ovarian cancer. Around 400 patients annually will now access this "biological missile" treatment that doubles as their first option when chemotherapy stops working.
Researchers created an AI tool that predicts which ovarian cancer treatments will work best for each patient right at diagnosis, using slides doctors already have. The breakthrough could help patients avoid ineffective chemotherapy and find better options faster.
After two decades, women with hard-to-treat ovarian cancer finally have a new option. The targeted therapy offers more precious time with loved ones and dramatically fewer side effects than traditional chemotherapy.
UC San Diego researchers discovered how to "re-educate" immune cells to attack aggressive ovarian cancer by blocking a protein and triggering omega-3 signals. The breakthrough could make existing treatments far more effective for patients with limited options.
A Dalhousie University lab just received $725,000 to develop a breakthrough immunotherapy for ovarian cancer, with help from a 73-year-old survivor who's turning her diagnosis into hope for future generations. The team is now preparing for clinical trials that could make treatment more affordable and accessible.
Showing 20 of 2960